1-3 of 3
Romualdo Barroso-Sousa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PD-1/PD-L1 Inhibition Enhances Chemotherapy-Induced Neuropathic Pain by Suppressing Neuroimmune Antinociceptive Signaling

Available to Purchase
Carlos Wagner S. Wanderley, Alexandre G.M. Maganin, Beatriz Adjafre, Atlante S. Mendes, Conceição Elidianne Anibal Silva, Andreza Urba Quadros, João Paulo Mesquita Luiz, Camila Meirelles S. Silva, Nicole R. Silva, Francisco Fabio Bezerra Oliveira, Francisco Isaac F. Gomes, Jeferson Leandro J. Restrepo, Cesar A. Speck-Hernandez, Fernanda Turaça, Gabriel Victor Lucena Silva, Glauce R. Pigatto, Helder I. Nakaya, Jose Mauricio Mota, Romualdo Barroso-Sousa, José C. Alves-Filho, Thiago M. Cunha, Fernando Q. Cunha
Journal: Cancer Immunology Research
Cancer Immunol Res (2022) 10 (11): 1299–1308.
https://doi.org/10.1158/2326-6066.CIR-22-0003
Published: 02 November 2022
View articletitled, PD-1/PD-L1 Inhibition Enhances Chemotherapy-Induced Neuropathic Pain by Suppressing Neuroimmune Antinociceptive Signaling
Open the PDF for PD-1/PD-L1 Inhibition Enhances Chemotherapy-Induced Neuropathic Pain by Suppressing Neuroimmune Antinociceptive Signaling in another window
Includes: Supplementary data
Journal Articles

The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor–Related Thyroid Disorders

Free
Chanjuan Ma, F. Stephen Hodi, Anita Giobbie-Hurder, Xiaocheng Wang, Jing Zhou, Amy Zhang, Ying Zhou, Fei Mao, Trevor E. Angell, Chelsea P. Andrews, Jiani Hu, Romualdo Barroso-Sousa, Ursula B. Kaiser, Sara M. Tolaney, Le Min
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (7): 1214–1220.
https://doi.org/10.1158/2326-6066.CIR-18-0613
Published: 01 July 2019
View articletitled, The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor–Related Thyroid Disorders
Open the PDF for The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor–Related Thyroid Disorders in another window
Includes: Supplementary data
Journal Articles

Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy

Free
Hyunju Lee, F. Stephen Hodi, Anita Giobbie-Hurder, Patrick A. Ott, Elizabeth I. Buchbinder, Rizwan Haq, Sara Tolaney, Romualdo Barroso-Sousa, Kevin Zhang, Hilary Donahue, Meredith Davis, Maria E. Gargano, Kristina M. Kelley, Rona S. Carroll, Ursula B. Kaiser, Le Min
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (12): 1133–1140.
https://doi.org/10.1158/2326-6066.CIR-17-0208
Published: 30 November 2017
View articletitled, Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy
Open the PDF for Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy in another window